Dr. Oklu is a co-founder and CMO of Obsidio, Inc. He is a Professor of Vascular & Interventional Radiology and the Director of NIH-funded Minimally Invasive Therapeutics Laboratory at Mayo Clinic. He is a Yale, Cambridge, Northwestern, Columbia, Harvard Medical School, and Massachusetts General Hospital educated and trained clinician-scientist. As a clinician, he has performed thousands of angiograms and hundreds of embolizations; as a scientist, he has significant biomaterials experience. His expertise also includes a Ph.D. in molecular biology and biochemistry and development of small and large animal models of disease. Dr. Oklu’s focus in the laboratory includes solving patient-inspired problems with a focus on translational approaches to practical problems in medicine. His work comprises of novel biomaterials as a tool to treat acute and chronic bleeding, bioengineering approaches to deliver and to capture drugs or byproducts of metabolism, biosensors on intravascular and indwelling catheters, and new medical devices for the treatment of venous thrombosis, catheter infections, and obesity. He has authored over 180 peer-reviewed peer-reviewed journal articles, editorials, and review papers.